Webb10 feb. 2024 · Corvus Pharmaceuticals, Inc. (“Corvus” or the “Company”) (b) Address of Issuer’s Principal Executive Offices: 863 Mitten Road Suite 102 Burlingame, CA 94010 Item 2. (a) Name of Persons Filing: Richard A. Miller (“Dr. Miller”) Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Webb3 apr. 2024 · Corvus Pharmaceuticals, Inc. anunció datos provisionales que demuestran el potencial del CPI-818, el inhibidor de la ITK de la empresa, para el tratamiento del linfoma de células T en la 10ª Cumbre ...
Corvus Pharmaceuticals on LinkedIn: Our co-founder and CEO, …
Webb8 maj 2024 · Richard Miller was the only individual insider to buy shares in the last twelve months. Richard Miller bought 135.71k shares over the last 12 months at an average … Webb9 aug. 2024 · Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET. Company Participants. Leiv Lea - Chief Financial Officer. … centers for mobility prosthetics
Co-Founder Richard Miller Just Bought 2.8% More Shares …
WebbDr. Richard Miller currently serves as co-founder, president and chief executive officer of Corvus Pharmaceuticals, a public biotechnology company. He co-founded and was chief … WebbHe is Chairman of Edgewise Therapeutics, Inc. (which he founded in 2024), Chief Executive Officer & Director at Terremoto Biosciences, Inc. (which he founded) and General Partner for OrbiMed Advisors Private Equity. Dr. Thompson is also Professor at the University of Washington and on the board of 11 other companies. Webb10 feb. 2024 · MILLER RICHARD A MD - CRVS / Corvus Pharmaceuticals Inc / MILLER RICHARD A MD - SC 13G/A Passive Investment - SC 13G/A - February 10, 2024; SC 13G/A … centers for mobility houston